Emerging Clinical Diagnostics Market in China Poised for Steady Growth

New York, November 21, 2005 — With steady growth over the last 10 years and a current assessment at $703 million, the China in vitro diagnostics market offers an increasingly attractive opportunity for manufacturers and distributors, according to a study released today from Kalorama Information. A changing Chinese healthcare environment with emphasis on privatization and China’s accession to the World Trade Organization — with its resulting reduction in tariffs and easing of distribution regulations — have opened the doors for clinical diagnostics to be one of the most promising emerging markets in the world.

Clinical Diagnostics in China: Market Sector Analysis and Participant Directory predicts that recent shifts in government health policy —the ending of Ministry of Health hospital evaluations, the ceasing of state support for hospital facilities, and the phasing-out of free, government-supported medical treatment and shift towards personal/corporate health spending responsibility — have set the stage for a free market economy ripe with potential for expansion in diagnostics, both reagents and instruments.

“As the regulatory climate continues to change, we’ll see the emergence of more private labs and expanded reference labs capable of leading the way to a more highly sophisticated diagnostic milieu” notes Steven Heffner, the publisher of Kalorama Information. “While there will continue to be pitfalls in the Chinese system, such as challenges with IVD product registration, the overall medical need and economic drivers are creating a growth market of unprecedented value.”

The study examines seven market sectors: coagulation, critical care chemistry, hematology, immunochemistry, molecular testing, routine chemistry, and urine chemistry. Perhaps of greatest value is the report’s extensive listing of market participants including profiles of 24 international manufacturers, 88 domestic manufacturers, and 57 local distributors.

Produced jointly with the firm McEvoy and Farmer, Clinical Diagnostics in China: Market Sector Analysis and Participant Directory can be purchased directly from Kalorama Information by clicking http://www.kaloramainformation.com/pub/1163780.html. It is also available at MarketResearch.com.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or sheffner@kaloramainformation.com, or visit www.KaloramaInformation.com.

About MarketResearch.com
With over 91,000 research publications from 350 research publishers, MarketResearch.com is the leading provider of global market intelligence products and services. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit www.MarketResearch.com.